Dr Reddy's Labs Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
5,392.00
7,679.00
7,201.00
6,048.00
3,061.00
2,883.00
Adjustment
2,708.00
1,961.00
1,365.00
1,695.00
2,333.00
2,087.00
Changes In working Capital
-1,074.00
-2,998.00
-2,018.00
-785.00
-1,840.00
-828.00
Cash Flow after changes in Working Capital
7,026.00
6,642.00
6,548.00
6,958.00
3,554.00
4,141.00
Cash Flow from Operating Activities
5,673.00
4,642.00
4,543.00
5,887.00
2,810.00
3,570.00
Cash Flow from Investing Activities
-6,425.00
-5,785.00
-4,034.00
-4,108.00
-2,565.00
-2,254.00
Cash Flow from Financing Activities
829.00
1,891.00
-376.00
-2,686.00
-242.00
-29.00
Net Cash Inflow / Outflow
77.00
748.00
132.00
-907.00
3.00
1,285.00
Opening Cash & Cash Equivalents
1,459.00
710.00
577.00
1,485.00
1,482.00
196.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
1,536.00
1,459.00
710.00
577.00
1,485.00
1,482.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Dr Reddy's Labs
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
5392.7
6026.7
-634.00
-10.52%
Adjustment
2708.2
1020.4
1,688.00
165.41%
Changes In working Capital
-1074.6
1531.5
-2,605.00
-170.17%
Cash Flow after changes in Working Capital
7026.3
8578.6
-1,552.00
-18.10%
Cash Flow from Operating Activities
5673.7
6776.7
-1,103.00
-16.28%
Cash Flow from Investing Activities
-6425.2
-8377.1
1,952.00
23.30%
Cash Flow from Financing Activities
829
2014.2
-1,185.00
-58.84%
Net Cash Inflow / Outflow
77.5
413.8
-336.00
-81.27%
Opening Cash & Cash Equivalents
1459.3
413
1,046.00
253.34%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
1536.8
826.8
710.00
85.87%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 22.20% vs 2.19% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
5,673.70
4,642.80
22.20%






